MX2012009538A - Metodo para la determinacion de variantes de secuencia de polipeptido. - Google Patents

Metodo para la determinacion de variantes de secuencia de polipeptido.

Info

Publication number
MX2012009538A
MX2012009538A MX2012009538A MX2012009538A MX2012009538A MX 2012009538 A MX2012009538 A MX 2012009538A MX 2012009538 A MX2012009538 A MX 2012009538A MX 2012009538 A MX2012009538 A MX 2012009538A MX 2012009538 A MX2012009538 A MX 2012009538A
Authority
MX
Mexico
Prior art keywords
amino acid
acid sequence
sample
evaluation
data
Prior art date
Application number
MX2012009538A
Other languages
English (en)
Inventor
Hans Koll
Joerg Thomas Regula
Anne Zeck
Frank Wiegeshoff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2012009538A publication Critical patent/MX2012009538A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención está dirigida a un método para. determinare mutaciones de una secuencia de aminoácido en un polipéptido producido, que comprende los siguientes pasaos de a) proporcionar una muestra de un polipéptido producido, b) incubar el polipéptido en la muestra con una proteasa, c) llevar a cabo un análisis bidimensional utilizando cromatografía de fase inversa acoplada con una espectroscopía de masas de alta resolución (FT-ICR/FT-orbitrap) y análisis Ms/MS de los fragmentos de la secuencia de aminoácido de los péptidos, d) evaluación de los datos comparando los grupos de datos LC-MS obtenidos para las muestras paralelamente con el grupo de datos de un muestra de referencia, mediante la búsqueda de diferencias en las intensidades de señal a tiempos de retención dados y por la evaluación de las señales diferenciales con respecto a las mutaciones de la secuencia de aminoácido. La muestra de referencia para la evaluación de los datos (d) puede ser ya sea un estándar bien caracterizado o una de las muestras a ser analizada.
MX2012009538A 2010-02-18 2011-02-16 Metodo para la determinacion de variantes de secuencia de polipeptido. MX2012009538A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10001645 2010-02-18
PCT/EP2011/052282 WO2011101370A1 (en) 2010-02-18 2011-02-16 Method for the determination of sequence variants of polypeptides

Publications (1)

Publication Number Publication Date
MX2012009538A true MX2012009538A (es) 2012-08-31

Family

ID=42224873

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012009538A MX2012009538A (es) 2010-02-18 2011-02-16 Metodo para la determinacion de variantes de secuencia de polipeptido.

Country Status (12)

Country Link
US (3) US20120322093A1 (es)
EP (1) EP2537035B1 (es)
JP (1) JP5903051B2 (es)
KR (1) KR20120120500A (es)
CN (1) CN102762987B (es)
BR (1) BR112012017532A2 (es)
CA (1) CA2787898A1 (es)
ES (1) ES2609669T3 (es)
MX (1) MX2012009538A (es)
RU (1) RU2012138298A (es)
SG (2) SG183320A1 (es)
WO (1) WO2011101370A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10371675B2 (en) * 2014-06-24 2019-08-06 Shimadzu Corporation Data processing device for comprehensive two-dimensional chromatograph
US10781484B1 (en) 2015-09-30 2020-09-22 Agilent Technologies, Inc. Method of oligonucleotide analysis
CN110418849A (zh) * 2017-02-03 2019-11-05 隆扎有限公司 分析多个细胞和检测生物产品制造中的蛋白质序列变体的方法
WO2019051103A1 (en) * 2017-09-06 2019-03-14 Lawrence Livermore National Security, Llc METHODS AND SYSTEMS FOR EXECUTING GENETICALLY MODIFIED PROTEIN ANALYSIS, AND ASSOCIATED MARKER PROTEIN GENETIC VARIATIONS AND DATABASES
JP7135561B2 (ja) * 2018-08-08 2022-09-13 株式会社島津製作所 分析制御装置、分析システムおよび分析方法
JP6996451B2 (ja) * 2018-08-24 2022-01-17 株式会社島津製作所 分析支援装置および分析支援方法
US11726096B2 (en) * 2018-10-04 2023-08-15 Regeneron Pharmaceuticals, Inc. Fast protein sequencing
CN113406336B (zh) * 2021-06-15 2024-06-07 上海臻复医疗科技有限公司 一种适用于质谱鉴定的毛干蛋白质提取方法及其应用
AU2023204745A1 (en) * 2022-01-10 2024-07-25 Regeneron Pharmaceuticals, Inc. Improved sequence variance analysis by proteominer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114168A1 (en) * 1993-03-05 1994-09-06 Zlatko Dembic Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
US7158862B2 (en) * 2000-06-12 2007-01-02 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method and system for mining mass spectral data
CN1376692A (zh) * 2001-03-22 2002-10-30 上海博德基因开发有限公司 一种多肽——免疫球蛋白轻链κ1蛋白－26.07和编码这种多肽的多核苷酸
EP1446667A2 (en) * 2001-11-13 2004-08-18 Caprion Pharmaceuticals, Inc. Mass intensity profiling system and uses thereof
WO2003046577A1 (en) * 2001-11-30 2003-06-05 The European Molecular Biology Laboratory A system and method for automatic protein sequencing by mass spectrometry
CN1774511B (zh) * 2002-11-27 2013-08-21 斯昆诺有限公司 用于序列变异检测和发现的基于断裂的方法和系统
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
GB0308202D0 (en) * 2003-04-09 2003-05-14 King S College London A screening method using mass spectrometry
ATE510025T1 (de) * 2005-12-13 2011-06-15 Inst Curie Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs

Also Published As

Publication number Publication date
EP2537035B1 (en) 2016-11-16
KR20120120500A (ko) 2012-11-01
US20150064735A1 (en) 2015-03-05
JP5903051B2 (ja) 2016-04-13
JP2013519099A (ja) 2013-05-23
WO2011101370A1 (en) 2011-08-25
SG183320A1 (en) 2012-09-27
US20210371897A1 (en) 2021-12-02
EP2537035A1 (en) 2012-12-26
CA2787898A1 (en) 2011-08-25
CN102762987A (zh) 2012-10-31
SG10201501080VA (en) 2015-04-29
ES2609669T3 (es) 2017-04-21
RU2012138298A (ru) 2014-03-27
BR112012017532A2 (pt) 2019-09-24
CN102762987B (zh) 2016-03-30
US20120322093A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
MX2012009538A (es) Metodo para la determinacion de variantes de secuencia de polipeptido.
Anjo et al. SWATH‐MS as a tool for biomarker discovery: From basic research to clinical applications
Schrader et al. Historical perspective of peptidomics
Villanueva et al. Isotope dilution mass spectrometry for absolute quantification in proteomics: concepts and strategies
Yang et al. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides
Wu et al. Five-plex isotope dimethyl labeling for quantitative proteomics
WO2010021822A3 (en) Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
Tsai et al. Mass spectrometry-based strategies for protein disulfide bond identification
Dong et al. The NISTmAb tryptic peptide spectral library for monoclonal antibody characterization
Torsetnes et al. Immunocapture and LC–MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum
Burnum-Johnson et al. Simultaneous proteomic discovery and targeted monitoring using liquid chromatography, ion mobility spectrometry, and mass spectrometry
WO2012097081A3 (en) Protein detection method
MX2018009339A (es) Métodos para la identificación y análisis de secuencias de aminoácidos de las proteínas.
WO2009078362A1 (ja) 低濃度エタノール試料の同位体比分析方法
Vinciguerra et al. Identification of proteinaceous binders in paintings: A targeted proteomic approach for cultural heritage
Park et al. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer
Mekhssian et al. Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma
Krisp et al. Online Peptide Fractionation Using a Multiphasic Microfluidic Liquid Chromatography Chip Improves Reproducibility and Detection Limits for Quantitation in Discovery and Targeted Proteomics*[S]
Luan et al. Elevated excretion of biopyrrin as a new marker for idiopathic Parkinson's disease
WO2013184995A8 (en) Methods and apparatus for performing mass spectrometry
Konno et al. Highly accurate and precise quantification strategy using stable isotope dimethyl labeling coupled with GeLC-MS/MS
WO2011003182A8 (en) Methods for early detection of blood disorders
Colzani et al. Relative protein quantification by isobaric SILAC with immonium ion splitting (ISIS)
Mesmin et al. Complexity reduction of clinical samples for routine mass spectrometric analysis
Higdon et al. IPM: An integrated protein model for false discovery rate estimation and identification in high-throughput proteomics

Legal Events

Date Code Title Description
FA Abandonment or withdrawal